Urinary proteomic biomarkers of adaptive bone formation and stress injuries in military recruits

The Defense Health Agency awarded Rosalind Franklin University of Medicine & Science $3.419 million on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on urinary proteomic biomarkers of adaptive bone formation and stress injuries in military recruits.

The project runs through August 31, 2030, with performance based in North Chicago, Illinois. The research investigates biomarkers in urine that may identify bone adaptation and injury patterns in service members undergoing recruit training, with potential applications to battlefield medicine and occupational health in the military population.

Rosalind Franklin University, a private non-profit health sciences institution, serves as the prime recipient and will conduct the research directly. The award is classified as a Project Grant under the Defense Health Program's Military Medical Research and Development portfolio, which supports basic, applied, and advanced biomedical research to improve health care delivery for service members and the American public.